This paper is in the following e-collection/theme issue:
Non-randomized Protocols and Methods (ehealth) (567) Myocardial Infarction (Heart Attack) (44) Precision Medicine and Genetics (48) Cardiac Disease Management (94) Cardiac Risk and Cardiac Risk Calculators (45) Coronary Heart Disease (81)Published on in Vol 11, No 2 (2022): February
Preprints (earlier versions) of this paper are
available at
https://preprints.jmir.org/preprint/31885, first published
.
Investigating Genetic and Other Determinants of First-Onset Myocardial Infarction in Malaysia: Protocol for the Malaysian Acute Vascular Events Risk Study
Investigating Genetic and Other Determinants of First-Onset Myocardial Infarction in Malaysia: Protocol for the Malaysian Acute Vascular Events Risk Study
Authors of this article:
Rajiv Chowdhury1, 2 ; Mohd Fairulnizal Md Noh3 ; Sophia Rasheeqa Ismail3 ; Kim Robin van Daalen1 ; Puteri Sofia Nadira Megat Kamaruddin3 ; Siti Hafizah Zulkiply3 ; Nur Hayati Azizul3 ; Norhayati Mustafa Khalid3 ; Azizan Ali3 ; Izyan Mohd Idris3 ; Yong Shih Mei3 ; Shazana Rifham Abdullah3 ; Norfashihah Faridus3 ; Nur Azirah Md Yusof3 ; Nur Najwa Farahin M Yusoff3 ; Rahman Jamal4 ; Aizai Azan Abdul Rahim5 ; Abdul Kahar Abdul Ghapar6 ; Ammu Kutty Radhakrishnan7 ; Alan Yean Yip Fong8, 9 ; Omar Ismail10 ; Saravanan Krishinan11 ; Chuey Yan Lee12 ; Liew Houng Bang13 ; Eashwary Mageswaren14 ; Kauthaman Mahendran15 ; Nor Hanim Mohd Amin16 ; Gunavathy Muthusamy17 ; Aaron Ong Hean Jin18 ; Ahmad Wazi Ramli19 ; Noel Thomas Ross20 ; Anwar Irawan Ruhani21 ; Mansor Yahya3 ; Yusniza Yusoff22 ; Siti Khairani Zainal Abidin14 ; Laryssa Amado1 ; Thomas Bolton1, 23 ; Sophie Weston1 ; Jason Crawte1 ; Niko Ovenden1 ; Ank Michielsen1 ; Md Mostafa Monower24 ; Wan Rozita Wan Mahiyuddin3 ; Angela Wood1, 23, 25, 26 ; Emanuele Di Angelantonio1, 23, 25, 26 ; Nur Suffia Sulaiman3 ; John Danesh1, 23, 25, 26, 27 ; Adam S Butterworth1, 23, 25, 26Journals
- Ab Rahman N, King T, Peariasamy K, Sivasampu S. Risk of major adverse cerebro-cardiovascular events following BNT162b2, CoronaVac, and ChAdOx1 vaccination and SARS-CoV-2 infection: A self-controlled case-series study. Vaccine 2024;42(26):126465 View